WO2007070637A3 - Method of treating open wounds using hypochlorous acid - Google Patents

Method of treating open wounds using hypochlorous acid Download PDF

Info

Publication number
WO2007070637A3
WO2007070637A3 PCT/US2006/047705 US2006047705W WO2007070637A3 WO 2007070637 A3 WO2007070637 A3 WO 2007070637A3 US 2006047705 W US2006047705 W US 2006047705W WO 2007070637 A3 WO2007070637 A3 WO 2007070637A3
Authority
WO
WIPO (PCT)
Prior art keywords
open wounds
hypochlorous acid
saline solution
treating open
electrolyzed saline
Prior art date
Application number
PCT/US2006/047705
Other languages
French (fr)
Other versions
WO2007070637A2 (en
Inventor
Joe B Selkon
Original Assignee
Puricore Inc
Joe B Selkon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Puricore Inc, Joe B Selkon filed Critical Puricore Inc
Priority to EP06845416A priority Critical patent/EP1959972A4/en
Publication of WO2007070637A2 publication Critical patent/WO2007070637A2/en
Publication of WO2007070637A3 publication Critical patent/WO2007070637A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0076—Sprayable compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Abstract

Methods for treating open wounds, such as chronic refractory open wound, by administering an electrolyzed saline solution comprising hypochlorous acid are provided. Method of alleviating the pain associated with open wounds by administering an electrolyzed saline solution are also provided. Combination treatment methods are also provided where an electrolyzed saline solution is administered subsequent to or concurrently with standard compression bandaging.
PCT/US2006/047705 2005-12-13 2006-12-13 Method of treating open wounds using hypochlorous acid WO2007070637A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP06845416A EP1959972A4 (en) 2005-12-13 2006-12-13 Method of treating open wounds using hypochlorous acid

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74958205P 2005-12-13 2005-12-13
US60/749,582 2005-12-13

Publications (2)

Publication Number Publication Date
WO2007070637A2 WO2007070637A2 (en) 2007-06-21
WO2007070637A3 true WO2007070637A3 (en) 2008-05-02

Family

ID=38163522

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/047705 WO2007070637A2 (en) 2005-12-13 2006-12-13 Method of treating open wounds using hypochlorous acid

Country Status (2)

Country Link
EP (1) EP1959972A4 (en)
WO (1) WO2007070637A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9381214B2 (en) 2011-03-18 2016-07-05 Puricore, Inc. Methods for treating skin irritation
US11452778B2 (en) 2011-03-18 2022-09-27 Urgo Us, Inc. Stabilized hypohalous acid solutions
ES2741480T3 (en) 2011-03-18 2020-02-11 Urgo Us Inc Stabilized solutions of hypohalous acid
EP2543359A1 (en) * 2011-07-08 2013-01-09 Caliopa AG Gel for use in wound treatment
DE102011055182A1 (en) * 2011-11-09 2013-05-16 Monopharm Beratungs- Und Handelsgesellschaft Mbh Anolyte, process for its preparation and its use
US20140328945A1 (en) * 2013-05-03 2014-11-06 Aquaxo, Inc. METHOD FOR STABILIZING AN ELECTROCHEMICALLY GENERATED SANITIZING SOLUTION HAVING A PREDETERMINED LEVEL OF FREE AVAILABLE CHLORINE AND pH
US10390874B2 (en) 2013-11-14 2019-08-27 Rm2 Technology Llc Methods, systems, and apparatuses for tissue ablation using electrolysis and permeabilization
US10939949B2 (en) 2015-05-01 2021-03-09 Inter Science Gmbh Methods, systems, and apparatuses for tissue ablation using pulse shape designs
CN108849971A (en) * 2018-07-15 2018-11-23 西安青叶生物科技有限公司 A kind of preparation and its application method using acidulous hypochlorous acid's type thimerosal
US20220079981A1 (en) * 2020-09-15 2022-03-17 Facerestoration Ltd Lavage techniques and virucidal compositions comprising hypochlorous solutions
CN113244264A (en) * 2021-06-07 2021-08-13 青岛威巴克生物技术有限公司 Novel protective agent for promoting healing of ulcer surface

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040137078A1 (en) * 2000-01-12 2004-07-15 Ramin Najafi Physiologically balanced, ionized, acidic solution and methodology for use in wound healing
US20040208940A1 (en) * 1999-08-23 2004-10-21 Sterilox Medical (Europe) Limited Wound and ulcer treatment with super-oxidized water

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6333054B1 (en) * 1999-10-21 2001-12-25 Amuchina S.P.A. Topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties
US20050139808A1 (en) * 2003-12-30 2005-06-30 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution and process for producing same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040208940A1 (en) * 1999-08-23 2004-10-21 Sterilox Medical (Europe) Limited Wound and ulcer treatment with super-oxidized water
US20040137078A1 (en) * 2000-01-12 2004-07-15 Ramin Najafi Physiologically balanced, ionized, acidic solution and methodology for use in wound healing

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1959972A4 *

Also Published As

Publication number Publication date
EP1959972A4 (en) 2009-06-03
EP1959972A2 (en) 2008-08-27
WO2007070637A2 (en) 2007-06-21

Similar Documents

Publication Publication Date Title
WO2007070637A3 (en) Method of treating open wounds using hypochlorous acid
PH12018500767A1 (en) Pharmaceutical composition, methods for treating and uses thereof
EA201300522A1 (en) PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF METABOLIC DISORDERS
UA98125C2 (en) Substituted dihydropyrazolon for the treatment of cardiovascular and haematological diseases
WO2010029089A3 (en) Combination therapy for the treatment of diabetes and related conditions
AU2011328009A8 (en) Compounds and methods for treating pain
EA201000515A1 (en) АКТИВАТОРЫ ГЛЮКОКИНАЗЫ
MX2019005130A (en) Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin.
WO2008057933A3 (en) Methods of treating neuropathic pain by modulation of glycogenolysis or glycolysis pathways
WO2009050506A3 (en) Combination 059
HK1122803A1 (en)
MX2009009417A (en) Piperidinyl-piperidine and piperazinyl-piperidine for use in the treatment of diabetes or pain.
AU2010300611A8 (en) Hematopoietic stem cells for use in the treatment of a kidney injury
UA105487C2 (en) Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases
WO2005070450A3 (en) Use of low-dose erythropoietin for the treatment of acute or chronic kidney failure and for the treatment of wounds
EA033397B1 (en) Method of treating prediabetes, type 1 or type 2 diabetes mellitus or improving glycemic control in a patient with said disorders
MX2013003060A (en) Combination therapy for treating hcv infection.
WO2010008573A3 (en) Wound healing
WO2013028818A8 (en) Pyrimido- pyridazinone compounds and use thereof
EA201390703A1 (en) SUBSTITUTED SODIUM-1H-PYRAZOL-5-OLAT
MY164998A (en) Isoquinolinone derivatives as nk3 antagonists
MA32416B1 (en) SUBSTITUTED 7-SULFANYLMETHYL-, 7-SULFINYMETHYL-AND 7-SULFONYLMETHYL-INDOLES AND THEIR USE
WO2007100590A3 (en) Methods for treating cellulite
NZ702666A (en) A method of weight reduction
MX2010002046A (en) Treatment of lung cancer.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006845416

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE